Successful treatment of pyoderma gangrenosum complicated by JAK2V617F mutation-positive myelofibrosis with adalimumab and systemic steroid

Saved in:
Bibliographic Details
Main Authors: Kyohei Shibuta, Koremasa Hayama, Katsuhiro Miura, Hideki Fujita
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-01-01
Series:Journal of Cutaneous Immunology and Allergy
Subjects:
Online Access:https://www.frontierspartnerships.org/articles/10.3389/jcia.2025.14079/full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832590055299874816
author Kyohei Shibuta
Koremasa Hayama
Katsuhiro Miura
Hideki Fujita
author_facet Kyohei Shibuta
Koremasa Hayama
Katsuhiro Miura
Hideki Fujita
author_sort Kyohei Shibuta
collection DOAJ
format Article
id doaj-art-7078a35a47f742ebb784b2d2fce68737
institution Kabale University
issn 2574-4593
language English
publishDate 2025-01-01
publisher Frontiers Media S.A.
record_format Article
series Journal of Cutaneous Immunology and Allergy
spelling doaj-art-7078a35a47f742ebb784b2d2fce687372025-01-24T04:12:03ZengFrontiers Media S.A.Journal of Cutaneous Immunology and Allergy2574-45932025-01-01810.3389/jcia.2025.1407914079Successful treatment of pyoderma gangrenosum complicated by JAK2V617F mutation-positive myelofibrosis with adalimumab and systemic steroidKyohei Shibuta0Koremasa Hayama1Katsuhiro Miura2Hideki Fujita3Division of Cutaneous Science, Department of Dermatology, Nihon University School of Medicine, Tokyo, JapanDivision of Cutaneous Science, Department of Dermatology, Nihon University School of Medicine, Tokyo, JapanDivision of Hematology and Oncology, Department of Internal Medicine, Nihon University School of Medicine, Tokyo, JapanDivision of Cutaneous Science, Department of Dermatology, Nihon University School of Medicine, Tokyo, Japanhttps://www.frontierspartnerships.org/articles/10.3389/jcia.2025.14079/fullpyoderma gangrenosummyelofibrosisadalimumabruxolitinibJanus Kinase 2
spellingShingle Kyohei Shibuta
Koremasa Hayama
Katsuhiro Miura
Hideki Fujita
Successful treatment of pyoderma gangrenosum complicated by JAK2V617F mutation-positive myelofibrosis with adalimumab and systemic steroid
Journal of Cutaneous Immunology and Allergy
pyoderma gangrenosum
myelofibrosis
adalimumab
ruxolitinib
Janus Kinase 2
title Successful treatment of pyoderma gangrenosum complicated by JAK2V617F mutation-positive myelofibrosis with adalimumab and systemic steroid
title_full Successful treatment of pyoderma gangrenosum complicated by JAK2V617F mutation-positive myelofibrosis with adalimumab and systemic steroid
title_fullStr Successful treatment of pyoderma gangrenosum complicated by JAK2V617F mutation-positive myelofibrosis with adalimumab and systemic steroid
title_full_unstemmed Successful treatment of pyoderma gangrenosum complicated by JAK2V617F mutation-positive myelofibrosis with adalimumab and systemic steroid
title_short Successful treatment of pyoderma gangrenosum complicated by JAK2V617F mutation-positive myelofibrosis with adalimumab and systemic steroid
title_sort successful treatment of pyoderma gangrenosum complicated by jak2v617f mutation positive myelofibrosis with adalimumab and systemic steroid
topic pyoderma gangrenosum
myelofibrosis
adalimumab
ruxolitinib
Janus Kinase 2
url https://www.frontierspartnerships.org/articles/10.3389/jcia.2025.14079/full
work_keys_str_mv AT kyoheishibuta successfultreatmentofpyodermagangrenosumcomplicatedbyjak2v617fmutationpositivemyelofibrosiswithadalimumabandsystemicsteroid
AT koremasahayama successfultreatmentofpyodermagangrenosumcomplicatedbyjak2v617fmutationpositivemyelofibrosiswithadalimumabandsystemicsteroid
AT katsuhiromiura successfultreatmentofpyodermagangrenosumcomplicatedbyjak2v617fmutationpositivemyelofibrosiswithadalimumabandsystemicsteroid
AT hidekifujita successfultreatmentofpyodermagangrenosumcomplicatedbyjak2v617fmutationpositivemyelofibrosiswithadalimumabandsystemicsteroid